How to Help Your Patients Find Potaba in Stock: A Provider's Guide

Writing the prescription for Potaba is the easy part. Getting your patient to successfully fill it is another matter entirely. As a prescriber — whether you're a urologist managing Peyronie's disease, a rheumatologist treating scleroderma, or a dermatologist handling morphea — arming yourself and your staff with the right resources can dramatically reduce patient frustration and improve treatment adherence.

Why Patients Struggle to Fill Potaba Prescriptions

Potaba (potassium aminobenzoate) is not listed in an active FDA shortage, but its chronic scarcity at most retail pharmacies creates a real-world access problem. Chain pharmacies like CVS, Walgreens, and Rite Aid typically don't stock it because the prescription volume doesn't justify the inventory. Patients often spend hours calling pharmacies, only to be repeatedly told "we don't carry that."

The result: treatment delays, patient anxiety, and — in some cases — prescription abandonment. This is preventable with the right system in place.

Strategy 1: Set Expectations at the Point of Prescribing

The most effective intervention is simple: tell patients before they leave the office that Potaba may require extra effort to fill. A brief warning — "Most big chain pharmacies don't carry this drug; you may need to call a few places or use a service to locate it" — prevents patients from being blindsided and helps them take a proactive approach.

Ideally, send the prescription to a pharmacy you've already confirmed can source it, rather than leaving the patient to figure this out from scratch.

Strategy 2: Establish a Preferred Pharmacy Relationship

If you prescribe Potaba with any regularity, invest 10 minutes in identifying one or two independent or specialty pharmacies in your area that reliably stock or can reliably order it. Have your office manager call these pharmacies and ask: "We have patients on potassium aminobenzoate (Potaba) 500 mg. Do you stock this? How quickly can you get it?"

Once you've identified a reliable source, keep that pharmacy's name and number at your front desk. When writing a Potaba prescription, your staff can proactively tell patients: "We recommend calling Pharmacy X — they usually have this medication in stock or can order it within 2 days."

Strategy 3: Recommend Compounding as a Backup

If commercial Potaba capsules are consistently hard to source in your region, compounding pharmacies can prepare custom potassium aminobenzoate formulations. Powders mixed into a liquid may actually improve tolerability for patients who struggle with swallowing 24 or more capsules per day.

When writing compounding prescriptions, specify the dose in grams per dose and total daily dose clearly. Confirm that the compounding pharmacy is 503A-accredited and uses USP-grade potassium aminobenzoate.

Strategy 4: Direct Patients to medfinder

For patients who need hands-on help, medfinder is a service that calls pharmacies near the patient to determine which ones can fill their specific prescription. Patients provide their medication, dosage, and ZIP code, and medfinder contacts pharmacies on their behalf, then texts the patient results. This saves hours of phone tag and reduces callbacks to your office.

Consider including medfinder as a resource in your patient discharge instructions for any niche or difficult-to-fill medication.

Strategy 5: Give Patients a Lead-Time Buffer

Because Potaba is often used long-term, patients on stable therapy can run into trouble when they wait until the last day to refill. Train your team to process refill requests at least 10–14 days before supply runs out, especially when the pharmacy needs to special-order. Include a note in the patient's chart or after-visit summary: "Request refill 2 weeks before running out — may require special order."

Addressing Insurance Coverage Issues

Potaba and its generic, potassium aminobenzoate, are generally covered by most commercial insurance plans at Tier 2–3. However, some plans may require prior authorization — particularly for off-label uses. If your patient is starting Potaba, have your staff check the formulary status with the insurer proactively and initiate a prior authorization request before the first prescription is sent to the pharmacy. This prevents a situation where the patient locates the drug but can't afford it.

When Potaba Cannot Be Obtained: A Clinical Decision Framework

If a patient calls to report they cannot find Potaba after a genuine search effort (multiple pharmacies, a special order attempt, and a medfinder search), consider the following decision pathway:

Determine whether treatment continuation is clinically urgent.

For Peyronie's disease patients: consider bridging with pentoxifylline or daily tadalafil while the supply issue is resolved.

For scleroderma or other fibrotic conditions: consult with the relevant specialist (rheumatologist, dermatologist) to determine whether therapy modification is indicated.

Document the access issue and your clinical decision in the medical record.

For a broader look at clinical alternatives, see Potaba Shortage: What Providers and Prescribers Need to Know in 2026.